Though Mounjaro has garnered significant interest due to its dual-action capability involving both GLP-1 and GIP receptors, it is crucial to understand that it is not approved for weight loss
And for some reason, nobody is talking about how athletes could be using this very expensive drug to improve their performance, and most shocking, is that as of recording this video, it is an approved substance by WADA, the World Anti-Doping Agency
While semaglutide has been associated with improvements in markers of kidney function in some patients, there have been reports of acute kidney injury, usually related to dehydration from gastrointestinal side effects
They do not meet program requirements established by CMS
Abstract Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) comprise a group of illnesses marked by memory and behavioral dysfunction that can occur in up to 50% of HIV patients despite adequate treatment with combination antiretroviral drugs
Severe or unusual symptoms warrant immediate medical evaluation